| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Department of Molecular Pathology, Research Institute, Aichi Cancer Center, Nagoya 464-8681 [K. Te., N. K-K., O. T., K. K., Re. K.]; Department of Biochemistry, Osaka University Medical School, Suita, Osaka 565-0871 [S. H., N. T.]; Department of Dermatology, Kyoto University School of Medicine, Kyoto 606-8507 [K. To.]; Department of Otolaryngology, Osaka Medical College, Takatsuki City, Osaka 569-8686 [Ry. K.]; and Department of Otorhinolaryngology, Kyoto Prefectural University of Medicine, Kyoto 602-0841 [K. Te., Y. H.], Japan
 |
ABSTRACT |
|---|
 Top ABSTRACT INTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
3ß1-integrin. F-2 cells cultured on Matrigel showed evident tube formation, and coculture of F-2 cells with A431 cells led to the formation of A431 cell nests constantly surrounded by tube-like networks consisting of F-2 cells. This in vitro morphogenesis was inhibited by the addition of anti-sialyl Lex/Lea or anti-ß1-integrin antibodies, which led to the formation of cancer cell aggregates that were independent from the F-2 cell networks. This in vitro morphological appearance was exactly reproduced in the in vivo tumors, which were formed when the mixture of A431 and F-2 cells at the ratio of 10:1 were cotransplanted s.c. into the back of nude rats. The tumors of A431 supplemented with F-2 cells were profoundly vascularized throughout by the tubular structures formed by F-2 cells, the lumen of which contained the host rat blood cells. The tumor mass thus formed was an average 5.8-fold as large as control A431 tumors that were grown without F-2 cells. The co-injection of anti-Lex/Lea or anti-ß1-integrin antibodies produced a marked reduction in the size of A431 tumors, which were not vascularized and accompanied an independent tiny remnant clump of F-2 cells. The size of these A431 tumors did not differ significantly from those of control A431 tumors raised without F-2 cells. These results indicate that the interaction of tumor cells and endothelial cells in orderly tumor angiomorphogenesis is highly dependent on the action of cell adhesion molecules mediating the adhesion of cancer cells to endothelial cells, inhibition of which remarkably retards tumor growth and angiogenesis. |
INTRODUCTION |
|---|
|
TopABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
The direct interaction of cancer cells with endothelial cells may have physiological relevance, however, not only in hematogenous metastasis of cancer, but also in tumor angiogenesis. Cell adhesion mediated by selectins and their carbohydrate ligands has recently been suggested to be involved in the process of angiogenesis by bovine endothelial cells and human umbilical vein endothelial cells (14 , 15) . These studies were confined to angiogenesis by endothelial cells per se, and the roles of cell adhesion molecules in the interaction of cancer cells and endothelial cells in tumor angiogenesis remained to be studied. Various mechanisms have been proposed for the formation of tumor vasculature, which would involve direct or indirect interaction of cancer cells and endothelial cells, including the interaction of cancer cells with circulating endothelial progenitor cells (16 , 17) , as well as so-called mosaic blood vessels (18, 19, 20) . Nevertheless, only a few experimental systems are available to evaluate the interaction of cancer cells and endothelial cells (21 , 22) .
Considerable study on tumor angiogenesis has emphasized the need for humoral factors, such as vascular endothelial growth factor, basal fibroblast growth factor, and TGFß, which are secreted from malignant cells and support survival, proliferation, and/or maturation of endothelial cells. The importance of these humoral factors is already well established, but the roles played by the cell adhesion molecules have not been properly evaluated because of a lack of appropriate experimental systems to estimate the adhesive interaction between cancer cells and endothelial cells in the context of tumor angiogenesis, with a few exceptions (21) . The presence of actively proliferating and functional endothelial cells is essential for the study of tumor angiogenesis, whereas microvascular endothelial cells in cell culture generally have a limited life span. This could be the reason that the roles of humoral factors that support survival, proliferation, and/or maturation of endothelial cells have dominated the study of tumor angiogenesis, whereas the significance of cell adhesion molecules tends to remain in the background. To date, only a few endothelial cell lines are available that demonstrate enough of the fundamental characteristics of microvascular endothelial cells (21 , 23 , 24) .
In the present study, we use a cultured endothelial cell line, F-2 (23) , which does not need particular humoral factors for its survival and proliferation but retains expression of important cell adhesion molecules and an ability to exhibit significant tube formation. We first attempted to characterize in detail the adhesion molecules involved in the interaction of the endothelial cells with human cancer cells and then applied the F-2 cells for in vitro and in vivo studies of tumor angiogenesis. This experimental system was less affected by the humoral factors related to survival or proliferation of endothelial cells and served to disclose the inherent roles played by cell adhesion molecules in tumor angiogenesis.
|
MATERIALS AND METHODS |
|---|
|
TopABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
was obtained from Bachem Fine Chemicals Inc. (Torrance, CA), and TGFß was from Biomedical Technologies Inc. (Stoughton, MA).
Antibodies and Flow Cytometric Analysis.
Anti-sialyl Lex (SNH-3) was kindly supplied by Dr. Sen-Itiroh Hakomori, Pacific Northwest Research Foundation (Seattle, WA), and anti-sialyl Lea antibody (2D3; both murine IgM) was prepared as described previously (25)
. An antibody directed to CD29 (ß1-subunit; 4B4) was purchased from Coulter Immunology (Hialeah, FL), and antibodies to CD49b (2-subunit; Gi9), CD49c (3-subunit; M-KID2), CD49d (4-subunit; HP2/1), and CD49f (6-subunit; GoH3) were obtained from Immunotech (Marseille, France). Anti-V-integrin antibody (CD51; MAB1980) was from Chemicon International Inc. (Temecula, CA). Antimurine E-selectin antibody (10E9) was kindly provided by Dr. Dietmar Vestweber, Max-Plank-Institute für Immunobiologie (Freiburg, Germany; Ref. 26
). Antimurine P-selectin (clone RB40.34) was obtained from PharMingen (San Diego, CA), antirat LFA-1 (clone WT.3) was from Seikagaku Kogyo (Tokyo, Japan), and polyclonal rabbit antimurine laminin antibody was obtained from Bioscience Products, AG (Emmenbrücke, Switzerland). Antibodies against species-specific antigens such as antihuman, antirat, and antimouse antibodies conjugated with FITC or rhodamine were prepared by immunization of female rabbits with a mixture of viable lymphocytes from each species of animals as described previously (27)
. Rabbit antirat antisera were injected i.p. into a normal female BALB/c mouse for in vitro adsorption, and the antisera collected after 12 h were used as antibody against rat species-specific antigens (27)
. Antibodies against mouse species-specific antigens were obtained by a similar in vivo adsorption in F344 rats, and antibodies against human species-specific antigens were absorbed with both mice and rats.
Flow cytometric analysis was performed using FACScan (Becton Dickinson Immunocytometry Systems, Mountain View, CA) as described previously (28)
. The indirect immunofluorescence method was applied for staining of cells, using a FITC-labeled antimouse, -rat, or -rabbit immunoglobulin as the second antibody (Cappel, Malvern, PA; Silenus, Hawthorn, Australia). For treatment of A431 cells with rHB-EGF, the A431 cells were cultured in the medium without the addition of FCS and cultured for 24 h. To this, 20 ng/ml rHB-EGF, prepared as described previously (29, 30, 31)
, was added in the presence or absence of 100 µg/ml genistein (Research Biochemicals International, Natick, MA). For study of cytokine-induced selectin expression on F-2 cells, IL-1ß, TNF, or LPS was added, and the cells were cultured for 4 h at 37°C.
Assays for Cancer Cell Adhesion and Implantation to the F-2 Cell Monolayers.
Monolayer cell adhesion assay was used for evaluation of initial adhesion of A431 cells to F-2 cells. Briefly, the F-2 cells were cultured in a 24-well plate to form a monolayer. After the addition of the A431 cells (5 x 105 cells/well), the plate was incubated with rotation at 80 rpm for 30 min at room temperature (2
, 32)
. After nonadherent cells were washed out three times with PBS, the number of attached cells was counted directly under a microscope. For inhibition studies, the antibodies were preincubated with A431 cells at 25 µg/ml for 30 min at room temperature before application to the monolayer of F-2 cells (2
, 32)
.
For evaluation of implantation activity of cancer cells to the F-2 cells, the 24-well plate containing F-2 cell monolayers was centrifuged at 300 x g immediately after the addition of the A431 cells (5 x 105 cells/well), to avoid the possible effect of the initial step of adhesion mediated by selectins, and incubated in a CO2 incubator for 8 h in the case of A431 cells. The number of cancer cells implanted into the monolayer of F-2 cells was counted directly under a microscope.
Cell attachment assay to extracellular matrix molecules was performed as follows (31) . A 24-well plate was coated with 5 µg/ml collagen I (Seikagaku Kogyo, Tokyo, Japan) or 20 µg/ml laminin (Takara Shuzo, Otsu, Japan) at 4°C overnight, and the wells were washed three times with PBS. Unbound surfaces were blocked with 0.5% BSA in PBS for 1 h, and the wells were then washed three times with PBS. A431 cells (5 x 105) were added at a volume of 500 µl/well to each substrate-coated well and then incubated for 30 min at 37°C. The wells were then washed three times with PBS to remove unattached cells. The number of attached cells was counted directly under a microscope.
Tube Formation of F-2 Cells and in Vivo Tumor Formation in Nude Rats.
In some experiments, F-2 cells were cultured on Matrigel (13.6 mg/ml; Collaborative Biomedical Products, Bedford, MA) to form tube-like structures. For coculture experiments, A431 and F-2 cells were mixed at the ratio of 2:5, plated on the Matrigel-coated plates, and cultured for 72 h.
For in vivo tumor formation, A431 cells (5 x 106) were injected s.c. into the backs of F344 nude rats with or without 5 x 105 cells of the murine endothelial cell line F-2. Rats were sacrificed 21–25 days after transplantation of cells, and the harvested tumors were subjected to histological and immunohistochemical analyses. For inhibition studies, a mixture of anti-sialyl Lex and anti-sialyl Lea antibodies, or anti-ß1-integrin antibody (25 µg/ml), was injected into the backs of nude rats.
|
RESULTS |
|---|
|
TopABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
. This adhesion was observed equally well either at 4°C or 37°C and was not affected by rotating the incubation plates at 80 rpm, indicating that the initial adhesion was shear force-resistant and energy-independent. Adhesion reached a plateau 30 min after the addition of the cancer cells to the F-2 cell monolayers (Fig. 1b)
.
|
). The implantation process was clearly detectable at 3 h after addition of the A431 cells and was almost complete within 8 h (Fig. 1c)
. This secondary implantation process was observed at 37°C, but was significantly attenuated at or below room temperature. Rotation of the culture plate also significantly inhibited the implantation, indicating that the secondary implantation was shear force-labile and energy-dependent.
Expression of Selectin Ligands and Integrins on Cancer Cells.
To characterize the adhesion molecules involved in the initial adhesion and implantation, we analyzed the cell adhesion molecules expressed on A431 cells. A431 cells moderately expressed sialyl Lex and sialyl Lea, the established ligands for selectins (Fig. 2a)
. As for integrins, A431 cells strongly expressed ß1, 3, 6, and v and moderately expressed 2- and 5-integrin chains (Fig. 2a)
. No significant expression of 4- (Fig. 2a)
and 1-integrin (not shown) chains was observed.
|
3-integrin chain was significantly enhanced, whereas previous treatment with genistein abrogated the enhancing effect of HB-EGF (Fig. 2b)
. The specificity and time course of this enhancing effect are shown in Fig. 2, c and d
.
Expression of Selectins on F-2 Cells.
The cultured F-2 murine endothelial cells significantly expressed E-selectin on their surface (Fig. 3a)
. F-2 cells also significantly expressed laminin, but expressed P-selectin only weakly. Because an endothelial cell line that constitutively expresses E-selectin is rarely found, we studied the effects of culture conditions and various stimulations on the expression of E-selectin on F-2 cells. F-2 cells under routine culture conditions significantly expressed murine E-selectin, and its expression was modestly enhanced to 123 ± 18, 116 ± 17, and 110 ± 27% by the addition of IL-1ß, TNF, and LPS, respectively, in terms of fluorescence intensity (Fig. 3b)
. Addition of a mixture of IL-1ß, TNF, and LPS enhanced the expression of E-selectin up to 147 ± 11%, whereas expression was inhibited to 79 ± 23% by the addition of TGFß (Fig. 3b)
. The expression of E-selectin on F-2 cells was also affected by the growth condition of the cells. Proliferating F-2 cells in sparse or subconfluent culture expressed E-selectin more strongly, and its expression in the confluent state decreased to 42.6% of that in the subconfluent state (Fig. 3b)
. When the F-2 cells were cultured on Matrigel, they formed tube-like structures (see below) and still expressed murine E-selectin at a level similar to that expressed by the cells in the monolayer (Fig. 3b)
. These results indicated that the expression of E-selectin on F-2 cells was generally stable and that it may well interact with its ligands when the cells form tube-like structures as well as in monolayers. Moreover, cells in the proliferative stage will interact more closely with the cells expressing appropriate selectin ligands.
|
. This indicated that both sialyl Lex and sialyl Lea expressed on A431 cells (Fig. 1a)
were involved in the adhesion of A431 cells to F-2 cells. Anti-integrin antibodies, including anti-ß1, -2, -3, -6, and -v, covering the major integrins on the A431 cells did not affect the initial adhesion step of A431 cells to F-2 cells.
|
, whereas it was completely inhibited by anti-ß1-integrin antibody (Fig. 4a)
. The anti-ß1-integrin antibody used in this study was directed to human ß1-integrin and had no cross-reactivity to murine ß1-integrin, indicating that the ß1-integrin involved in the implantation process was expressed on the side of human cancer cells. The implantation of A431 cells was also completely inhibited by murine antihuman 3-integrin antibody (Fig. 4a)
, suggesting that the molecular species of the integrin involved in the process was mainly 3ß1-integrin. The participation of integrin in the implantation step was compatible with the temperature- and energy-dependent characteristics of the reaction. A431 cells exhibited significant binding to laminin and collagen, but not to fibronectin. The binding activity of 3ß1-integrin expressed on A431 cells was ascertained by the significant inhibition of binding of A431 cells to laminin by anti-3-integrin antibody as well as by anti-ß1-integrin antibody, as shown in Fig. 4b
. In contrast, the binding of A431 cells to collagen was mediated mainly by 2-integrin. In the analysis of secondary implantation step of cancer cells to the F-2 cell monolayer, the 24-well plate was first centrifuged with F-2 cell monolayers at 300 x g, immediately after the addition of the A431 cancer cells. This protocol was adopted to evaluate only the activities of the molecules involved in the process of implantation, not in the initial step of adhesion. Centrifugation of the plates ensured the close contact of cancer cells with the F-2 cell monolayers from the beginning of the incubation period, excluding any possible effects on the experimental results of the first step of cell adhesion. This may be the reason that the anti-sialyl Lex and anti-sialyl Lea antibodies had no effect on the implantation of the cancer cells in these assays. The overall interactions of cancer cells with the F-2 cells in vivo and in vitro would be expected to require the normal progression of these two sequential steps, i.e., initial adhesion and secondary implantation.
In Vitro Cooperation of Cancer Cells and Endothelial Cells.
F-2 cells formed tube-like network structures when cultured on Matrigel, as shown in Fig. 5a
. When A431 cells were cocultured with F-2 cells on Matrigel in vitro, tube formation of F-2 cells was invariably observed, which surrounded small aggregates of A431 cells in an orderly fashion (Fig. 5b)
. Prolonged culture led to the growth of cancer cell nests formed by A431 cells, which were clearly demarcated by the tubular networks of F-2 cells (Fig. 5c)
. The morphology, on the whole, closely resembled that of natural cancer tissues, where the cancer nests are surrounded by stroma tissues containing small blood vessels. Inclusion of the mixture of anti-sialyl Lex/Lea antibodies or anti-ß1-integrin antibody in the culture medium inhibited the interaction of A431 cells with F-2 cells and led to the accumulation of A431 cell aggregates, which were formed independently from the meshwork of F-2 cells (Fig. 5, d and e)
.
|
The growth of A431 tumors supplemented with F-2 cells was much more rapid than the growth of tumors formed by the A431 cells only, and the difference was statistically significant (typical results are shown in Table 1
). On average, A431 tumors 
5.8-fold larger than control were formed by the co-injection of F-2 cells (Table 1
and Fig. 6
). By microscopic observation, the A431 tumors thus formed by co-injection of F-2 cells were characterized by vigorous vascularization, in which blood vessel-like structures developed in almost every cancer cell nest (Fig. 6)
to form small, medium-sized, and eventually large blood vessel-like structures (Fig. 7, a–c)
. This closely resembled the configuration observed in the in vitro coculture of A431 cells with F-2 cells on Matrigel, as indicated in Fig. 5c
. The tumors formed by A431 cells alone were very small and contained almost negligible vascularization of host origin (Fig. 6b)
. These control tumors also exhibited a strong tendency toward parakeratotic degeneration (Fig. 6b)
. Only cancer cells in the outermost thin layers just beneath the capsule were viable; the rest of the central tumor area contained degenerated eosinophilic materials (Fig. 6b)
.
|
|
|
. Only the small mesenchymal components in the stroma and outermost capsules were found to be of rat origin, whereas all of the cancer cells were of human origin (Fig. 7, f–h)
. The blood vessel-like structures contained WBCs stained significantly with antirat LFA-1 antibody (Fig. 7d)
, indicating that the blood vessels were somewhere connected to the systemic circulation of the host nude rats. These results indicated that the co-injection of the murine endothelial cell line led to the vigorous vascularization of A431 tumors, which encouraged them to grow much faster than control tumors transplanted without F-2 cells.
Significance of Cell Adhesion Molecules in the in Vivo Growth of A431 Tumors.
The accelerative effect of F-2 cell co-injection for tumor growth was abrogated by concomitant administration of the mixtures of anti-sialyl Lex/Lea antibodies or anti-ß1-integrin antibody (typical experimental results are summarized in Table 1
). The sizes of A431 tumors formed in the presence of these antibodies were in the same range as those of tumors raised without F-2 cell co-injection (Table 1)
. The A431 tumors formed in the presence of these antibodies were very small, and again showed poor vascularization under microscopic observation. Viable cancer cells were found only in a thin layer just beneath the capsules, and the major central area of tumors contained diffuse, nonviable keratinoid materials (Fig. 8, a and b)
. The morphology of these tumors was essentially the same as that of the tumors raised without the co-injection of F-2 cells except for some remnant small aggregates of F-2 cells, occasionally attached to the tail portion of the main A431 tumors outside the capsules. These morphological findings were in a clear contrast to those seen in the large and well-vascularized tumors obtained without the addition of antibodies (Fig. 8c)
.
|
|
DISCUSSION |
|---|
|
TopABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
3ß1-integrin, which is known to react with several ligands, including laminin, collagen, and fibronectin (35
, 36)
. The counter receptor on F-2 cells for 3ß1-integrin is most probably laminin because it is expressed on F-2 cells and clear inhibition of binding of A431 cells to laminin was obtained by anti-3-integrin antibody.
Sialyl Lex and sialyl Lea were constitutively expressed on A431 cells, whereas expression of E-selectin on endothelial F-2 cells was affected by cytokines and proliferative states of the cells. The characteristics of the F-2 cells used in this study were in several aspects different from those of cultured human endothelial cells. First, expression of E-selectin on F-2 cells was less affected by treatment with cytokines, such as IL-1ß or TNF, compared with that on cultured human endothelial cells, such as human umbilical vein endothelial cells. Second, the F-2 cells constitutively expressed E-selectin, whereas human endothelial cells usually express virtually no E-selectin under normal culture conditions. F-2 cells in the proliferative stage are thought to more strongly interact with cancer cells expressing selectin ligands. In these aspects, the F-2 cells are very similar to bovine endothelial cells (14)
. Preferential expression of E-selectin on proliferating endothelial cells in tissues in which growth of microvessels is ongoing has been reported in several human tissues, such as dividing microvascular endothelial cells in placenta and neonatal foreskin (37)
.
It is noteworthy that HB-EGF, which is produced by endothelial cells (33
, 34)
, augmented the expression of 3ß1-integrin on A431 cells. This enhancing effect was abrogated by the inhibitor of the EGF receptor kinase, genistein. Various investigators, including some of the authors of the present report, have shown that growth stimulation by EGF or HB-EGF treatments significantly augments integrin expression on cancer cells (38, 39, 40)
. This suggests preferential enhancement of integrin expression, including 3-chains, on the subpopulation of growth-stimulated cancer cells. Taken together, these findings suggest that the cancer cells and F-2 cells, both in the proliferative stage, preferentially interact and undergo cell adhesion and implantation.
A unique characteristic of F-2 cells is their ability to form three-dimensional tubular network structures when cultured on Matrigel-coated plates (23) . Selectin-mediated adhesion and integrin-mediated implantation of cancer cells were consistently observed with cultured endothelial cells either in monolayer or in the form of tubular network structures. Several investigators have suggested the possible involvement of selectin-carbohydrate interactions in the in vitro tube formation of cultured endothelial cells (14 , 41) . The introduction of anti-E-selectin or anti-sialyl Lex/Lea antibodies into F-2 cells failed to inhibit Matrigel-induced tube formation, even after the transfection of E-selectin or glycosyltransferase cDNA to further augment the expression of selectin and its ligands (data not shown). Together with the findings on the apparent normal development of blood vessels in mice with disrupted selectin genes (42 , 43) , this would indicate the presence of selectin-dependent and -independent pathways in the tube formation of cultured endothelial cells and the highly cell context-dependent role of cell adhesion molecules in angiogenesis. However, angiogenesis sometimes depends on the interaction of endothelial cells with other types of cells, and the roles of cell adhesion molecules in such interaction remain to be studied. It is noteworthy that the in vitro angiogenesis of bovine aortic endothelial cells induced by polymorphonuclear leukocytes requires adhesion of leukocytes to endothelial cells through E-selectin and integrin/intercellular adhesion molecule-1 interaction (44 , 45) . When added to the coculture of F-2 cells with A431 cells, the anti-sialyl Lex/Lea antibodies as well as anti-ß1-integrin antibody significantly inhibited the interaction of endothelial cells with cancer cells. The orderly formation of cancer cell nests surrounded by functional vascular networks of F-2 cells was almost completely inhibited by these antibodies both in vitro and in vivo. Our results indicated that the interaction of cancer cells with endothelial cells through adhesion molecules such as selectins and integrins is critical for generation of functional vascular networks nourishing cancer cell nests and promoting in vivo growth of tumors. The novel in vitro and in vivo model experimental systems described here offer a unique opportunity to study direct or indirect interaction between cancer cells and endothelial cells together with the outcome.
|
FOOTNOTES |
|---|
1 This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (13680732 and on priority areas 14030092); grants-in-aid for the Second Term Comprehensive Ten-Year Strategy for Cancer Control from the Ministry of Health, Labor and Welfare, Japan; and a grant from the Princess Takamatsu Foundation for the Promotion of Cancer Research. 
2 To whom requests for reprints should be addressed, at Department of Molecular Pathology, Research Institute, Aichi Cancer Center, 1-1 Kanokoden, Chikusaku, Nagoya 464-8681, Japan. Fax: 81-52-701-1787; E-mail: rkannagi{at}aichi-cc.jp
3 The abbreviations used are: E-selectin, endothelial-leukocyte adhesion molecule-1; Lea and Lex, Lewis a and Lewis x; TGFß, tumor growth factor-ß; IL-1ß, interleukin-1ß; TNF, tumor necrosis factor-; LFA-1, lymphocyte function-associated antigen-1; HB-EGF, heparin-binding epidermal growth factor; LPS, lipopolysaccharide.
Received 5/26/02. Accepted 8/27/02.
|
REFERENCES |
|---|
|
TopABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
(1,3)fucosyltransferase antisense sequences inhibits selectin-mediated adhesion and liver metastasis of colon carcinoma cells. Cancer Res., 59: 2127-2135, 1999.1
3 fucosyltransferase VII and newly cloned GlcNAcß:6-sulfotransferase cDNA. Proc. Natl. Acad. Sci. USA, 96: 4530-4535, 1999.2ß1 and 3ß1 in cell-cell and cell-substrate adhesion of human epidermal cells. J. Cell Biol., 110: 1387-1404, 1990.3ß1 in epithelial basement membranes. Cell, 65: 599-610, 1991.[Medline]
2ß1 integrin expression. Exp. Cell Res., 216: 261-272, 1995.[Medline]
This article has been cited by other articles:
|
|
 |
|
  W. Yan, B. Bentley, and R. Shao Distinct Angiogenic Mediators Are Required for Basic Fibroblast Growth Factor- and Vascular Endothelial Growth Factor-induced Angiogenesis: The Role of Cytoplasmic Tyrosine Kinase c-Abl in Tumor Angiogenesis Mol. Biol. Cell, May 1, 2008; 19(5): 2278 - 2288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bruno, B. Bussolati, C. Grange, F. Collino, M. E. Graziano, U. Ferrando, and G. Camussi CD133+ Renal Progenitor Cells Contribute to Tumor Angiogenesis Am. J. Pathol., December 1, 2006; 169(6): 2223 - 2235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Bagley, W. Weber, C. Rouleau, and B. A. Teicher Pericytes and Endothelial Precursor Cells: Cellular Interactions and Contributions to Malignancy Cancer Res., November 1, 2005; 65(21): 9741 - 9750. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Matsui, H. Kojima, H. Suzuki, H. Hamajima, H. Nakazato, K. Ito, A. Nakao, and J. Sakamoto Sialyl Lewisa Expression as a Predictor of the Prognosis of Colon Carcinoma Patients in a Prospective Randomized Clinical Trial Jpn. J. Clin. Oncol., October 1, 2004; 34(10): 588 - 593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Duda, D. Fukumura, L. L. Munn, M. F. Booth, E. B. Brown, P. Huang, B. Seed, and R. K. Jain Differential Transplantability of Tumor-Associated Stromal Cells Cancer Res., September 1, 2004; 64(17): 5920 - 5924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Miyazaki, K. Ohmori, M. Izawa, T. Koike, K. Kumamoto, K. Furukawa, T. Ando, M. Kiso, T. Yamaji, Y. Hashimoto, et al. Loss of Disialyl Lewisa, the Ligand for Lymphocyte Inhibitory Receptor Sialic Acid-Binding Immunoglobulin-Like Lectin-7 (Siglec-7) Associated with Increased Sialyl Lewisa Expression on Human Colon Cancers Cancer Res., July 1, 2004; 64(13): 4498 - 4505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Koike, N. Kimura, K. Miyazaki, T. Yabuta, K. Kumamoto, S. Takenoshita, J. Chen, M. Kobayashi, M. Hosokawa, A. Taniguchi, et al. Hypoxia induces adhesion molecules on cancer cells: A missing link between Warburg effect and induction of selectin-ligand carbohydrates PNAS, May 25, 2004; 101(21): 8132 - 8137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Walter-Yohrling, X. Cao, M. Callahan, W. Weber, S. Morgenbesser, S. L. Madden, C. Wang, and B. A. Teicher Identification of Genes Expressed in Malignant Cells That Promote Invasion Cancer Res., December 15, 2003; 63(24): 8939 - 8947. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
